Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7648197 | 0.82 | ALDH1A1 (0.40) | ALDH1A1LMNATP53HPGDTSHR | |
| SCHEMBL8164102 | 0.73 | — | — | |
| SCHEMBL13049890 | 0.66 | LMNA (0.36) | ALDH1A1LMNATSHRHSD17B10 | |
| SCHEMBL22411242 | 0.61 | — | — | |
| SCHEMBL8419246 | 0.61 | — | — | |
| SCHEMBL22783953 | 0.61 | — | — | |
| SCHEMBL22411236 | 0.61 | — | — | |
| SCHEMBL22411237 | 0.60 | — | — | |
| SCHEMBL8164372 | 0.59 | — | — | |
| SCHEMBL27446122 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9408853-B2 | Iridium/rhodium anti-cancer compounds | UNIVERSITY OF WARWICK (GB) | 2016-08-09 | — | — | US | disclosed |
| EP-2734554-A1 | METHOD FOR PREPARING DIALKYL MAGNESIUM COMPOUNDS BY ETHYLENE POLYMERISATION AND USES THEREOF | Universite De Lille 1 Sciences Et Technologies (FR) | 2014-05-28 | — | — | EP | disclosed |
| EP-2575801-A1 | NOVEL IRIDIUM/RHODIUM ANTI-CANCER COMPOUNDS | University of Warwick (GB) | 2013-04-10 | — | — | EP | disclosed |
| US-20130065864-A1 | NOVEL IRIDIUM/RHODIUM ANTI-CANCER COMPOUNDS | UNIVERSITY OF WARWICK (GB) | 2013-03-14 | — | — | US | disclosed |
| WO-2013014383-A1 | METHOD FOR PREPARING DIALKYL MAGNESIUM COMPOUNDS BY ETHYLENE POLYMERISATION AND USES THEREOF | UNIVERSITE DE LILLE 1 SCIENCES ET TECHNOLOGIES (FR) | 2013-01-31 | — | — | WO | disclosed |
| US-8293327-B2 | Process for forming the strontium-containing thin film | KABUSHIKIKAISHA KOJUNDOKAGAKU KENKYUSHO (JP) | 2012-10-23 | — | — | US | disclosed |
| WO-2011148124-A1 | NOVEL IRIDIUM/RHODIUM ANTI-CANCER COMPOUNDS | UNIVERSITY OF WARWICK (GB) | 2011-12-01 | — | — | WO | disclosed |
| US-7635441-B2 | Raw material for forming a strontium-containing thin film and process for preparing the raw material | KABUSHIKIKAISHA KOJUNDOKAGAKU KENKYUSHO (JP) | 2009-12-22 | — | — | US | disclosed |
| US-20090001618-A1 | RAW MATERIAL FOR FORMING A STRONTIUM-CONTAINING THIN FILM AND PROCESS FOR PREPARING THE RAW MATERIAL | KABUSHIKIKAISHA KOJUNDOKAGAKU KENKYUSHO (JP) | 2009-01-01 | — | — | US | disclosed |
| US-20090004383-A1 | PROCESS FOR FORMING THE STRONTIUM-CONTAINING THIN FILM | KABUSHIKIKAISHA KOJUNDOKAGAKU KENKYUSHO (JP) | 2009-01-01 | — | — | US | disclosed |
| CN-1136548-A | Process for preparation of cyclopentadinyl compounds and compounds obtained therefrom | MONTELL TECHNOLOGY COMPANY BV (NL) | 1996-11-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130065864-A1 | NOVEL IRIDIUM/RHODIUM ANTI-CANCER COMPOUNDS | RBBP5, ANXA5, RAB35 | ALDH1A1 2305/4885LMNA 4198/4885TP53 23/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.